首页> 外文期刊>Molecules >A Novel Method HPLC-DAD Analysis of the Contentsof Moutan Cortexand Paeoniae Radix Alba with Similar Constituents-Monoterpene Glycosides in Guizhi Fuling Wan
【24h】

A Novel Method HPLC-DAD Analysis of the Contentsof Moutan Cortexand Paeoniae Radix Alba with Similar Constituents-Monoterpene Glycosides in Guizhi Fuling Wan

机译:桂枝Fu陵湾牡丹皮和Pa药中类似成分-莫替芬糖苷的含量的新型HPLC-DAD分析

获取原文
获取原文并翻译 | 示例
           

摘要

A variety of traditional Chinese medical formulations contain two or more herbs from the same genus or family. Although these herbs may have a similar appearance and constituents, they usually have different pharmacodynamic actions. A series of qualitative and quantitative analysis methods are developed to determine one or more compounds for quality control of medicine. As far as we know, no method has been found to determine the real ratio of the two herbs along with the prescription. In this study, we used HPLC-DAD as a way to determine the content of Moutan cortex (M) and Paeoniae radix alba (P) in GuizhiFuling Wan (GZFLW). An effective, accurate and reliable HPLC-DAD method was developed for detecting the content of M and P in GZFLW through the analysis of four monoterpeneglycosides, namely, galloylpaeoniflorin (1), paeoniflorin (2), mudanpioside C (3) and benzoylpaeoniflorin (4). Due to the different UV characteristics of the compounds, the detection wavelength was 270 nm for 1 and 2, while 3 and 4 were monitored at 254 nm and 230 nm, respectively. Four equations were put forward to describe the relationship between content of M as well as P and the four monoterpene glycosides in GZFLW. After validation, all the accuracies of the M and P contents in GZFLW were within 10%. The result showed that the method could be successfully applied to analyze the contents of M and P in GZFLW. Moreover, our method may be more widely used to control the quality of proprietary Chinese medicines, especially for those containing the same genus or family herbs, in industrial GMP production.
机译:各种传统的中药配方都包含两种或两种以上来自同一属或家族的草药。尽管这些草药可能具有相似的外观和成分,但它们通常具有不同的药效作用。开发了一系列定性和定量分析方法,以确定一种或多种用于药物质量控制的化合物。据我们所知,尚未找到确定处方中两种草药的实际比例的方法。在本研究中,我们使用HPLC-DAD作为测定桂枝福灵湾(GZFLW)的牡丹皮(M)和白e(Peoniae radix alba(P))含量的方法。建立了一种有效,准确,可靠的HPLC-DAD方法,通过分析四种单萜糖苷,即没药苷(1),pa药苷(2),丹皮甙C(3)和苯甲酰eon药苷(4)来检测GZFLW中的M和P )。由于化合物的紫外线特性不同,因此1和2的检测波长为270 nm,而3和4的检测波长分别为254 nm和230 nm。提出了四个方程来描述GZFLW中M和P的含量与四个单萜糖苷之间的关系。验证后,GZFLW中所有M和P含量的准确度均在10%以内。结果表明,该方法可以成功地用于分析GZFLW中M和P的含量。而且,在工业GMP生产中,我们的方法可能会更广泛地用于控制中成药的质量,特别是对于包含相同属或家庭草药的中成药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号